Prophylactic Efficacy of Intravenous Nefopam Versus Ondansetron in Preventing Post-Spinal Shivering in Parturients Undergoing Elective Caesarean Section: A Double-Blind Randomised Controlled Trial.

Background: Post-spinal shivering (PSS) is a frequent complication of spinal anaesthesia during caesarean section, causing patient discomfort and potential physiological disturbances. Both nefopam and ondansetron possess anti-shivering properties; however, comparative evidence in obstetric patients is limited. The objective of this study is to compare the efficacy and safety of intravenous nefopam and ondansetron in preventing post-spinal shivering in women undergoing elective caesarean section under spinal anaesthesia. Methodology: This randomised controlled study included 96 ASA II parturients scheduled for elective caesarean section under spinal anaesthesia. Participants were randomly allocated into three groups (n = 32 each). Group N received intravenous nefopam (0.15 mg/kg), Group O received intravenous ondansetron (0.1 mg/kg), and Group P received 10 mL of normal saline as a placebo. The medications were administered 15 minutes before spinal anaesthesia. Patients were monitored for the incidence and severity of shivering using the Crossley and Mahajan scale. Side effects and the need for rescue medication (intravenous pethidine 0.5 mg/kg) were also recorded. Statistical significance was set at p < 0.05. Results: The incidence of PSS was significantly lower in Group N (18.8%) and Group O (18.8%) compared with Group P (59.4%) (p < 0.001). Severe shivering (grades 3-4) occurred only in the placebo group (40.5%). Consequently, the need for rescue pethidine was significantly higher in Group P (37.5%), while none of the patients in Groups N or O required it (p < 0.001). Postoperative nausea was less frequent in Group O (3.1%) and Group N (12.5%) compared with Group P (25%) (p < 0.05). Mild injection-site pain occurred only in Group N (9.4%). Conclusion: Intravenous nefopam and ondansetron are similarly effective in preventing post-spinal shivering and reducing rescue analgesia requirements during caesarean section under spinal anaesthesia. Ondansetron showed better antiemetic effect, while nefopam was associated with mild injection-site discomfort.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-08-03
Primary Topic
Thermal Regulation in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prophylactic Efficacy of Intravenous Nefopam Versus Ondansetron in Preventing Post-Spinal Shivering in Parturients Undergoing Elective Caesarean Section: A Double-Blind Randomised Controlled Trial.

Kefas Thomas Malau, Yohanna Musa Usman, Henry Y. Embu, Erdoo S. Isamade et al.
PubMed
Thermal Regulation in Medicine
article

Prophylactic Efficacy of Intravenous Nefopam Versus Ondansetron in Preventing Post-Spinal Shivering in Parturients Undergoing Elective Caesarean Section: A Double-Blind Randomised Controlled Trial.

Kefas Thomas Malau, Yohanna Musa Usman, Henry Y. Embu, Erdoo S. Isamade, Samuel I. Nuhu, Mangai Audu Ngeh, Husseina Amina Aliyu, Jude Adikwu Agbo, Precious Barisi Kpalap, Uga Donald Orshio, Aliyu Musa Abdullahi, Rimamkanati Christopher Shaki
article en

Abstract

Background: Post-spinal shivering (PSS) is a frequent complication of spinal anaesthesia during caesarean section, causing patient discomfort and potential physiological disturbances. Both nefopam and ondansetron possess anti-shivering properties; however, comparative evidence in obstetric patients is limited. The objective of this study is to compare the efficacy and safety of intravenous nefopam and ondansetron in preventing post-spinal shivering in women undergoing elective caesarean section under spinal anaesthesia. Methodology: This randomised controlled study included 96 ASA II parturients scheduled for elective caesarean section under spinal anaesthesia. Participants were randomly allocated into three groups (n = 32 each). Group N received intravenous nefopam (0.15 mg/kg), Group O received intravenous ondansetron (0.1 mg/kg), and Group P received 10 mL of normal saline as a placebo. The medications were administered 15 minutes before spinal anaesthesia. Patients were monitored for the incidence and severity of shivering using the Crossley and Mahajan scale. Side effects and the need for rescue medication (intravenous pethidine 0.5 mg/kg) were also recorded. Statistical significance was set at p < 0.05. Results: The incidence of PSS was significantly lower in Group N (18.8%) and Group O (18.8%) compared with Group P (59.4%) (p < 0.001). Severe shivering (grades 3-4) occurred only in the placebo group (40.5%). Consequently, the need for rescue pethidine was significantly higher in Group P (37.5%), while none of the patients in Groups N or O required it (p < 0.001). Postoperative nausea was less frequent in Group O (3.1%) and Group N (12.5%) compared with Group P (25%) (p < 0.05). Mild injection-site pain occurred only in Group N (9.4%). Conclusion: Intravenous nefopam and ondansetron are similarly effective in preventing post-spinal shivering and reducing rescue analgesia requirements during caesarean section under spinal anaesthesia. Ondansetron showed better antiemetic effect, while nefopam was associated with mild injection-site discomfort.

PubMedVol. 67(1)
University of Jos (NG), Federal Medical Centre (NG), Jos University Teaching Hospital (NG)
Good health and well-being
Openalex Percentile: Top 7%
Thermal Regulation in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.